Strategic partnerships Finesse has a history of collaborations and acquisitions with Thermo Fisher Scientific, indicating a strong channel for partnerships and integration opportunities for their SmartPart and TruBio platforms. A targeted outreach to Thermo Fisher’s enterprise accounts to co-sell or co-develop turnkey bioprocess automation solutions could accelerate market reach.

Integrated platform The combination of TruBio software, G3 Universal controllers, and TruFluor sensors suggests a cohesive, interoperable automation stack that can modernize legacy bioprocesses. Position as a migration and retrofit solution for mid to large bioprocess plants seeking digital transformation and data harmonization.

Scale-up readiness Capabilities to support both small-scale R&D labs and cGMP SmartFactories indicate cross-segment appeal. Target contract manufacturers and biopharma sponsors looking to scale processes from pilot to commercial, with a single vendor for hardware, software, and validation services.

Single-use trend SmartVessel and TruFluor single-use sensors align with the industry shift toward disposable bioprocessing and faster changeovers. Market as a low-risk, high-uptime solution to shorten time-to-scale and reduce contamination risk for biologics and cell therapies.

Global transfer enablement TruBio software emphasizes easy technology transfer across sites and equipment, reducing knowledge gaps during expansions or site acquisitions. Use as a differentiator to win customers undergoing facility expansions, global rollouts, or mergers where standardization and data integrity are critical.